Cargando…

INCIDENCE OF HIGH GRADE QTCF PROLONGATION AND ITS MANAGEMENT AMONG PATIENTS UNDERGOING TREATMENT FOR DRUG RESISTANT TUBERCULOSIS (DR-TB): CASE SERIES.

BACKGROUND: The World Health Organization (WHO) has approved the use of two new drugs, namely Bedaquiline (Bdq) and Delamanid (Dlm), for treatment of Drug Resistant Tuberculosis (DR-TB). One of the concerns raised with the use of these drugs was QT-interval prolongation. This condition could be seri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asfaw, Meseret T., Holtzman, David L., Kwan, Gene F., Oyewusi, Lawrence T., Mitnick, Carole D., Seung, Kwonjune J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	African Traditional Herbal Medicine Supporters Initiative (ATHMSI) 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457348/ https://www.ncbi.nlm.nih.gov/pubmed/34595385 http://dx.doi.org/10.21010/ajidv15i2S.5

Ejemplares similares

COVID-19 in Patients with Drug-Resistant Tuberculosis in Lesotho
por: Andom, Afom T., et al.
Publicado: (2023)

The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
por: Khan, Uzma, et al.
Publicado: (2019)

A Randomized, Double‐Blind, Placebo‐ and Positive‐Controlled, 4‐Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy Participants
por: Zomorodi, Katie, et al.
Publicado: (2020)

Ascertainment Bias in TB Treatment Trials: Can Systematic Assessment of Objective Endpoints Solve It?
por: Mitnick, Carole D., et al.
Publicado: (2023)

Issues in design and interpretation of MDR-TB clinical trials: report of the first Global MDR-TB Clinical Trials Landscape Meeting
por: Mitnick, Carole D, et al.
Publicado: (2015)

Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion
por: Rodriguez, Carly A., et al.
Publicado: (2022)

Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different
por: LaHood, Allison, et al.
Publicado: (2022)

Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort( )
por: Hewison, Catherine, et al.
Publicado: (2022)

Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB
por: Zeng, C., et al.
Publicado: (2023)

Role Of Vitamin-D Supplementation In TB/HIV Co-Infected Patients
por: Ayelign, Birhanu, et al.
Publicado: (2020)

Early Outcomes of MDR-TB Treatment in a High HIV-Prevalence Setting in Southern Africa
por: Seung, Kwonjune J., et al.
Publicado: (2009)

The economic burden of TB-affected households in DR Congo
por: Kaswa, M., et al.
Publicado: (2021)

Sputum culture conversion definitions and analytic practices for multidrug-resistant TB
por: Rodriguez, C. A., et al.
Publicado: (2021)

TB research requires strong protections, innovation, and increased funding in response to COVID-19
por: Nyang’wa, B. T., et al.
Publicado: (2021)

Characteristics of TB/HIV Co-Infection and Patterns of Multidrug-Resistance Tuberculosis in the Northwest Amhara, Ethiopia
por: Seid, Aynias, et al.
Publicado: (2023)

Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting
por: van’t Boveneind-Vrubleuskaya, Natasha, et al.
Publicado: (2016)

Prolonged use of bedaquiline in the treatment for MDR-TB in a child
por: Gubkina, Marina F., et al.
Publicado: (2021)

Early mortality during rifampicin-resistant TB treatment
por: Mohr-Holland, E., et al.
Publicado: (2022)

The Reductionist Conundrum of an “Updated” Definition of Extensively Drug-Resistant Tuberculosis
por: Mitnick, Carole D., et al.
Publicado: (2021)

Intervening on Social Determinants for Better Outcomes in Pediatric Tuberculosis Management
por: de Almeida, Carlos Podalirio Borges, et al.
Publicado: (2023)

Comparison of censoring assumptions to reduce bias in tuberculosis treatment cohort analyses
por: Brooks, Meredith B., et al.
Publicado: (2020)

Assessment of training and mentoring for DR-TB care decentralization in Tanzania
por: Lyakurwa, Dennis, et al.
Publicado: (2021)

Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial
por: Milstein, Meredith, et al.
Publicado: (2016)

Prolonged B-Lymphocyte-Mediated Immune and Inflammatory Responses to Tuberculosis Infection in the Lungs of TB-Resistant Mice
por: Linge, Irina, et al.
Publicado: (2023)

Patients direct costs to undergo TB diagnosis
por: de Cuevas, Rachel M. Anderson, et al.
Publicado: (2016)

Assessment of Anti-TB Drug Nonadherence and Associated Factors among TB Patients Attending TB Clinics in Arba Minch Governmental Health Institutions, Southern Ethiopia
por: Gube, Addisu Alemayehu, et al.
Publicado: (2018)

Polymorphisms in CARD8 and NLRP3 are associated with extrapulmonary TB and poor clinical outcome in active TB in Ethiopia
por: Abate, Ebba, et al.
Publicado: (2019)

1576. Risk of Clinical Tuberculosis (TB) Among Patients with Latent TB Infection (LTBI) Who Undergo Allogeneic Hematopoietic-Cell Transplantation (HCT)
por: Kusztos, Amanda E, et al.
Publicado: (2018)

Grading diabetic retinopathy (DR) using the Scottish grading protocol
por: Zachariah, Sonia, et al.
Publicado: (2015)

Enhancing TB Case Detection: Experience in Offering Upfront Xpert MTB/RIF Testing to Pediatric Presumptive TB and DR TB Cases for Early Rapid Diagnosis of Drug Sensitive and Drug Resistant TB
por: Raizada, Neeraj, et al.
Publicado: (2014)

Investigating the response to COVID-19 and understanding severe TB cases: The 2022 Pulmonology TB series
por: Migliori, G.B., et al.
Publicado: (2022)

The Growing Problem of Multidrug-Resistant Tuberculosis in North Korea
por: Seung, Kwonjune J., et al.
Publicado: (2013)

Missing Cases of Bacteriologically Confirmed TB/DR-TB from the National Treatment Registers in West and North Sumatra Provinces, Indonesia
por: Widoyo, Ratno, et al.
Publicado: (2023)

Differential expression of chemokine receptors on monocytes in TB and HIV S
por: Tamene, Wegene, et al.
Publicado: (2023)

TB AND COVID-19 COINFECTION: A CASE SERIES
por: CÎRJALIU, R.-E., et al.
Publicado: (2022)

Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2015)

Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population
por: Raizada, Neeraj, et al.
Publicado: (2015)

Impact of Treatment Supporters on the Treatment Outcomes of Drug Resistant-Tuberculosis (DR-TB) Patients: A Retrospective Cohort Study
por: Giri, Om P, et al.
Publicado: (2022)

Extensively Drug-Resistant Tuberculosis, Lesotho
por: Satti, Hind, et al.
Publicado: (2008)

TB-06 Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma
por: Nakano, Tomoyuki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m8vb39g4gep4egeu7ahadmfnek